New York

State Director

Assistant State Directors

NYSTEM

Visit the NYSTEM  (New York State Stem Cell Science) web site.

Parkinson’s Disease-Related Federal Funding in New York

National Institutes of Health (NIH)

Non American Recovery and Reinvestment Act (Non-ARRA)
•    Winifred Masterson Burke Medical Research Institute
•    University of Rochester
•    Wadsworth Center
•    State University of New York at Buffalo
•    City College of New York
•    SUNY Downstate Medical Center
•    Feinstein Institute for Medical Research
•    Weill Medical College of Cornell University
•    Cornell University Ithaca
•    Nathan S. Kline Institute for Psych Research
•    Columbia University Health Sciences
•    State University New York Binghamton
•    New York Institute of Technology
•    World Parkinson Coalition, INC
•    Population Diagnostics, INC

Total Non-ARRA funding $14,265,133

Actual ARRA
•    Columbia University Health Sciences
•    Weill Medical College of Cornell University
•    University of Rochester
•    Hunter College
•    State University of New York at Buffalo University of Rochester
•    Winifred Masterson Burke Medical Research Institute

Total ARRA funding $2,765,153

Department of Veterans Affairs Parkinson’s Disease Research, Education and Clinical Centers (PADRECC) and Consortium Sites
•    Syracuse VA Medical Center in Syracuse, NY
•    James J. Peters VA Medical Center in Bronx, NY
•    Albany VA Medical Center in Albany, NY

Department of Defense (DoD)
Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program grantees:
•    Interaction of synuclein and inflammation in dopaminergic neurodegeneration in New York, NY
•    Role of miRNAS in Parkinson’s disease in New York, NY
•    Molecular Characterization of Cholinergic Cell Adaptions in Parkinson’s disease in New York, NY
•    Study of Calneuron, a possible therapeutic target for Parkinson disease in New York, NY
•    A Novel p11 Pathway as a Therapeutic Target for Parkinsons Disease in New York, NY
•    Molecular Basis of Selective Dopaminergic Cell Loss in Parkinson’s disease in New York, NY
•    Identification of cell-type specific targets for the treatment of Parkinson's Disease and PD-related Depression in New York, NY
•    Pre-Clinical Testing of New Hydroxybutyrate Analogues in New York, NY
•    Mechanisms of Alpha-Synuclein-induced Toxicity in Dopaminergic Neurons in Parkinson’s disease in New York, NY
•    Role of mGluR5/Norbin in Dyskinesia Associated with Parkinson's disease in New York, NY